SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-19-000063
Filing Date
2019-06-17
Accepted
2019-06-17 16:06:58
Documents
7
Period of Report
2019-06-17
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K bgne-form8xkcelgenexx17jun.htm 8-K 50885
2 EXHIBIT 99.1 a991abraxanenda_finalxen.htm EX-99.1 83457
3 EXHIBIT 99.2 a992eha_3zanupostersx61319.htm EX-99.2 32780
4 EXHIBIT 99.3 a993eha_tislechlx61319xen.htm EX-99.3 22454
5 a991abraxanendafinale_image.jpg GRAPHIC 193729
6 a992eha3zanuposters61_image1.jpg GRAPHIC 8672
7 a993ehatislechl61319e_image1.jpg GRAPHIC 193729
  Complete submission text file 0001651308-19-000063.txt   736524
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 19901488
SIC: 2834 Pharmaceutical Preparations